Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Inflammatory Bowel Diseases|August 5, 2010
Cancer in Crohn's Disease patients treated with infliximab: a long-term multicenter matched pair studyLivia Biancone, Carmelina Petruzziello, Ambrogio Orlando, et al.
United European Gastroenterology Journal|May 23, 2020
Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centreFranco Scaldaferri, Daniela Pugliese, Giuseppe Privitera, et al.
United European Gastroenterology Journal|March 21, 2023
Comparison of two strategies for the management of postoperative recurrence in Crohn's disease patients with one clinical risk factor: A multicentre IG-IBD studyGabriele Dragoni, Fabiana Castiglione, Cristina Bezzio, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 19, 2024
Suboptimal disease control and contributing factors in Italian IBD patients: The IBD-PODCAST StudyEmma Calabrese, Sara Onali, Angela Variola, et al.
Journal of Crohn'S & Colitis|March 18, 2014
Early post-operative endoscopic recurrence in Crohn's disease patients: data from an Italian Group for the study of inflammatory bowel disease (IG-IBD) study on a large prospective multicenter cohortAmbrogio Orlando, Filippo Mocciaro, Sara Renna, et al.
Therapeutic Advances in Gastroenterology|August 28, 2025
Real-world Effectiveness of Tofacitinib on Ulcerative Colitis-Associated Spondyloarthropathy: a multicenter prospective study from the Italian Group for the Study of Inflammatory Bowel Diseases (IG-IBD)Fabio Salvatore Macaluso, Mauro Grova, Fabrizio Bossa, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 14, 2025
IBD impact on quality of life and perception of disease activity in Italian patients and physicians: An IBD-PODCAST study sub analysisEdoardo Vincenzo Savarino, Flavio Andrea Caprioli, Davide Giuseppe Ribaldone, et al.
The New England Journal of Medicine|March 19, 2015
Mongersen, an oral SMAD7 antisense oligonucleotide, and Crohn's diseaseGiovanni Monteleone, Markus F Neurath, Sandro Ardizzone, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 21, 2013
Adalimumab in active ulcerative colitis: a "real-life" observational study, Alessandro Armuzzi, Livia Biancone, et al.
The American Journal of Gastroenterology|April 25, 2022
An Objective Comparison of Vedolizumab and Ustekinumab Effectiveness in Crohn's Disease Patients' Failure to TNF-Alpha InhibitorsSara Onali, Daniela Pugliese, Flavio Andrea Caprioli, et al.
Pageof 7